467
Views
18
CrossRef citations to date
0
Altmetric
Original article

Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis

, , &
Pages 1719-1731 | Accepted 01 Jul 2015, Published online: 08 Jul 2015

References

  • Stovall DW. Clinical symptomatology of uterine leiomyomas. Clin Obstet Gynecol 2001;44:364-71
  • Mayo Clinic. Uterine fibroids – Definition. Mayo Clinic, 2014
  • Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007;87:725-36
  • Gliklich RE, Leavy MB, Velentgas P, et al. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease. A Report on the Priority-Setting Process, Preliminary Data Analysis, and Research Plan. Rockville, MD: Agency for Healthcare Research and Quality; 2011. Available at: http://effectivehealthcare.ahrq.gov/reports/final.cfm [Last accessed 4 April 2015]
  • Gretz H, Bradley WH, Zakashansky K, et al. Patient clinical factors influencing use of hysterectomy in New York, 2001–2005. Am J Obstet Gynecol 2008;199:349.e1-5
  • ACOG Committee Opinion No. 444. Choosing the route of hysterectomy for benign disease. Obs Gynecol 2009;114:1156-8
  • Lurie S, Piper I, Woliovitch I, Glezerman M. Age-related prevalence of sonographicaly confirmed uterine myomas. J Obstet Gynaecol 2005;25:42-4
  • Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7
  • Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-8
  • Ezzati M, Norian JM, Segars JH. Management of uterine fibroids in the patient pursuing assisted reproductive technologies. Womens Health (Lond Engl) 2009;5:413-21
  • Marino JL, Eskenazi B, Warner M, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod 2004;19:2350-5
  • Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstet Gynecol Scand 2000;79:202-7
  • Selo-Ojeme D, Lawal O, Shah J, et al. The incidence of uterine leiomyoma and other pelvic ultrasonographic findings in 2,034 consecutive women in a North London hospital. J Obstet Gynaecol 2008;28:421-3
  • Tiltman AJ. Leiomyomas of the uterine cervix: a study of frequency. Int J Gynecol Pathol 1998;17:231-4
  • Foundation NUF. Uterine fibroids – Introduction. 2010. Available at: http://www.nuff.org/health.htm [Last accessed 4 April 2015]
  • McCool WF, Durain D, Davis M. Overview of latest evidence on uterine fibroids. Nurs Womens Health 2014;18:314-32
  • Zimmermann A, Bernuit D, Gerlinger C, et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health 2012;12:6
  • Singh SS, Belland L. Contemporary management of uterine fibroids: focus on emerging medical treatments. Curr Med Res Opin 2015;31:1-12
  • Sabry M, Al-Hendy A. Medical Treatment of Uterine Leiomyoma. Reprod Sci 2012;19:339-53
  • Levy BS. Modern management of uterine fibroids. Acta Obstet Gynecol Scand 2008;87:812-23
  • Coddington CC, Collins RL, Shawker TH, et al. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. Fertil Steril 1986;45:624-9
  • Letterie GS, Coddington CC, Winkel CA, et al. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. Fertil Steril 1989;51:951-6
  • Islam MS, Protic O, Giannubilo SR, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. J Clin Endocrinol Metab 2013;98:921-34
  • Mauskopf J, Flynn M, Thieda P, et al. The economic impact of uterine fibroids in the United States: a summary of published estimates. J Womens Health (Larchmt) 2005;14:692-703
  • Oderda G, Asche C, Jones KP, et al. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid. Arch Gynecol Obstet 2007;276:211-18
  • Carls GS, Lee DW, Ozminkowski RJ, et al. What are the total costs of surgical treatment for uterine fibroids? J Womens Health (Larchmt) 2008;17:1119-32
  • Dembek CJ, Pelletier EM, Isaacson KB, Spies JB. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids. J Vasc Interv Radiol 2007;18:1207-13
  • Griffiths A, D’Angelo A, Amso N. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2006;3:CD003857
  • Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91:1215-23
  • Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012;206:211.e1-9
  • Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 2010;152:96-102
  • Becker ER, Spalding J, DuChane J, Horowitz IR. Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998–2002. J Natl Med Assoc 2005;97:1336-42
  • Ascher SM, Jha RC, Reinhold C. Benign myometrial conditions: leiomyomas and adenomyosis. Top Magn Reson Imaging 2003;14:281-304
  • Huang JQ, Lathi RB, Lemyre M, et al. Coexistence of endometriosis in women with symptomatic leiomyomas. Fertil Steril 2010;94:720-3
  • Harmanli OH, Bevilacqua SA, Dandolu V, et al. Adenomyosis interferes with accurate ultrasonographic detection of uterine leiomyomas. Arch Gynecol Obstet 2005;273:146-9
  • Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 2006;108:930-7
  • Behera MA, Likes CE, Judd JP, et al. Cost analysis of abdominal, laparoscopic, and robotic-assisted myomectomies. J Minim Invasive Gynecol 2012;19:52-7
  • Beinfeld MT, Bosch JL, Gazelle GS. Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. Acad Radiol 2002;9:1300-4
  • Baker CM, Winkel CA, Subramanian S, Spies JB. Estimated costs for uterine artery embolization and abdominal myomectomy for uterine leiomyomata: a comparative study at a single institution. J Vasc Interv Radiol 2002;13:1207-10
  • Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 2006;195:955-64
  • Greenberg MD, Kazamel TI. Medical and socioeconomic impact of uterine fibroids. Obstet Gynecol Clin North Am 1995;22:625-36
  • Zhao SZ, Wong JM, Arguelles LM. Hospitalization costs associated with leiomyoma. Clin Ther 1999;21:563-75
  • Subramanian S, Clark MA, Isaacson K. Outcome and resource use associated with myomectomy. Obstet Gynecol 2001;98:583-7
  • Goldberg J, Bussard A, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization. Cardiovasc Intervent Radiol 2007;30:54-8
  • Becker ER. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures. J Health Care Finance 2007;33:1-16
  • Lee DW, Ozminkowski RJ, Carls GS, et al. The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids. J Occup Environ Med 2007;49:493-506
  • Hansen LG, Chang S. Health Research Data for the Real World: The MarketScan Databases. Thomson Reuters, 2012
  • Fuldeore M, Yang H, Du EX, et al. Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases. Fertil Steril 2015;103:163-71
  • DeWaay DJ, Syrop CH, Nygaard IE, et al. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 2002;100:3-7
  • Divakar H. Asymptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2008;22:643-54
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9
  • Lee DW, Gibson TB, Carls GS, et al. Uterine fibroid treatment patterns in a population of insured women. Fertil Steril 2009;91:566-74
  • US Bureau of Labor Statistics, Division of Consumer Prices and Price Indexes. How BLS Measures Price Change for Medical Care Services in the Consumer Price Index. Washington, DC: US Bureau of Labor Statistics, 2010
  • Crawford M, Church J, Rippy D, eds. CPI Detailed Report Data for January 2012. Washington, DC: US Bureau of Labor Statistics, 2012
  • Whiteman MK, Kuklina E, Jamieson DJ, et al. Inpatient hospitalization for gynecologic disorders in the United States. Am J Obstet Gynecol 2010;202:541.e1-6
  • Pfuntner A, Wier LM, Steiner C, Elixhauser A. Costs for Hospital Stays in the United States, 2011. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ), 2013
  • US Department of Commerce, Economic and Statistics Administration, US Census Bureau. Age and Sex Composition: 2010. Washington, DC: US Census Bureau, 2011
  • Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999;353:571-80
  • Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007;75:1503-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.